Skip to main content

Table 1 Patients’ characteristics

From: Insulin therapy and blood glucose management in critically ill patients: a 1-day cross-sectional observational study in 69 French intensive care units

 

Overall (n = 893)

Hospitalization < 7 days

(n = 517)

Hospitalization

 ≥ 7 days

(n = 376)

P value a

Missing (%)b

Demographics

Age, mean (SD)

61.6 (14.0)

61.9 (14.8)

61.3 (12.9)

0.51

0

 Male

597 (66.9)

336 (65.0)

261 (69.4)

0.19

0

 Days since admission

6 [2, 15]

3 [1, 5]

18 [12, 28]

 < 0.001

0

 Body mass index (kg/m2), mean (SD)

28.4 (8.0)

28.3 (7.6)

28.7 (8.5)

0.47

4.0

 Body weight (kg), mean (SD)

81.6 (22.7)

81.0 (22.0)

82.3 (23.8)

0.41

1.1

 SAPS2, mean (SD)

45.9 (19.3)

44.6 (19.3)

47.7 (19.2)

0.017

1.9

Reason for admission

 Septic shock

94 (10.5)

55 (10.6)

39 (10.4)

0.99

0

 Other shock

53 (5.9)

22 (4.3)

31 (8.2)

0.019

0

 Acute respiratory failure

485 (54.3)

265 (51.3)

220 (58.5)

0.037

0

 Coma

80 (9.0)

45 (8.7)

35 (9.3)

0.85

0

 Stroke

24 (2.7)

16 (3.1)

8 (2.1)

0.50

0

 Cardiac arrest

61 (6.8)

41 (7.9)

20 (5.3)

0.16

0

 Head trauma

8 (0.9)

1 (0.2)

7 (1.9)

0.024

0

 Other trauma

10 (1.1)

4 (0.8)

6 (1.6)

0.41

0

 Acute liver failure

7 (0.8)

3 (0.6)

4 (1.1)

0.67

0

 Acute kidney failure

47 (5.3)

36 (7.0)

11 (2.9)

0.012

0

 Surgery

60 (6.7)

42 (8.1)

18 (4.8)

0.12

0

 Other

81 (9.1)

46 (8.9)

35 (9.3)

0.93

0

Chronic illnesses

 Chronic arterial hypertension

425 (47.6)

239 (46.2)

186 (49.5)

0.31

0

 Chronic cardiac insufficiency

116 (13.0)

69 (13.3)

47 (12.5)

0.76

0

 Chronic lung insufficiency

174 (19.5)

105 (20.3)

69 (18.4)

0.55

0

 Chronic kidney disease

105 (11.8)

67 (13.0)

38 (10.1)

0.21

0

 Hemodialysis

26 (2.9)

20 (3.9)

6 (1.6)

0.07

0

 Cancer or hematologic malignancy

116 (13.0)

75 (14.5)

41 (10.9)

0.13

0

 Solid organ transplant

29 (3.2)

12 (2.3)

17 (4.5)

0.08

0

 Type 1 diabetes

8 (0.9)

5 (1.0)

3 (0.8)

 > 0.99

0

 Type 2 diabetes

204 (22.8)

104 (20.1)

100 (26.6)

0.024

0

 Cirrhosis

24 (2.7)

11 (2.1)

13 (3.5)

0.29

0

Chronic medications

 Long-acting insulin

55 (6.2)

23 (4.4)

32 (8.5)

0.019

0

 Short-acting insulin

49 (5.5)

19 (3.7)

30 (8.0)

0.008

0

 Intermediate insulin

4 (0.4)

2 (0.4)

2 (0.5)

 > 0.99

0

Characteristics on study day

 Temperature (°C)

37.0 [36.4, 37.5]

36.8 [36.3, 37.4]

37.1 [36.6, 37.6]

 < 0.001

2.2

 Infection

556 (62.3)

299 (57.8)

257 (68.4)

0.003

0

 Antibiotic

484 (54.2)

255 (49.3)

229 (60.9)

 < 0.001

0

 Vasopressor

240 (26.9)

145 (28.1)

95 (25.2)

0.44

0

 Mechanical ventilation

583 (67.5)

289 (55.9)

294 (78.2)

 < 0.001

0

 Enteral nutrition

429 (48.0)

155 (30.0)

274 (72.9)

 < 0.001

0

 Oral nutrition

231 (25.9)

176 (34)

55 (14.6)

 < 0.001

0

 Parenteral nutrition

91 (10.2)

38 (7.4)

53 (14.1)

0.001

0

 2.5% Glucose administration

60 (6.7)

26 (5.0)

34 [9]

0.021

0

 5% Glucose administration

580 (64.9)

332 (64.2)

248 (66)

0.422

0

 10% Glucose administration

40 (4.5)

34 (6.6)

6 (1.6)

 < 0.001

0

 AKI KDIGO > 0

257 (28.8)

144 (27.9)

113 [30]

0.50

0

 Corticosteroids within 3 days

355 (39.8)

224 (43.3)

131 (34.8)

0.015

0

 Glucagon

2 (0.2)

1 (0.2)

1 (0.3)

 > 0.99

0

 SOFA score on study day

5 [3, 8]

5 [2, 8]

5 [3, 8.25]

0.11

0.1

  1. Results expressed as number (percentage) or median (interquartile range) unless otherwise specified
  2. AKI acute kidney injury; KDIGO Kidney disease improving global outcomes [31]; IQR Interquartile range; SAPS2 Simplified acute physiology score [32]; SOFA sepsis related organ failure [18]
  3. aBetween-group differences in proportions were tested by Fisher exact test, excluding patients with missing values
  4. bPercentage of patients with missing value (over 893 patients)